56 related articles for article (PubMed ID: 27660711)
1. [Focus on the Immunoscore and its potential clinical implications].
El Sissy C; Marliot F; Haicheur N; Kirilovsky A; Scripcariu D; Lagorce-Pagès C; Galon J; Pagès F
Ann Pathol; 2017 Feb; 37(1):29-38. PubMed ID: 28161000
[TBL] [Abstract][Full Text] [Related]
2. Novel HALO® image analysis to determine cell phenotype in porous precision-templated scaffolds.
Chan NR; Hwang B; Waworuntu RL; Tran AJ; Ratner BD; Bryers JD
J Biomed Mater Res A; 2023 Sep; 111(9):1459-1467. PubMed ID: 37029696
[TBL] [Abstract][Full Text] [Related]
3. The current understanding of the immune landscape relative to radiotherapy across tumor types.
Iliadi C; Verset L; Bouchart C; Martinive P; Van Gestel D; Krayem M
Front Immunol; 2023; 14():1148692. PubMed ID: 37006319
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3
Rapoport BL; Nayler S; Mlecnik B; Smit T; Heyman L; Bouquet I; Martel M; Galon J; Benn CA; Anderson R
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626126
[TBL] [Abstract][Full Text] [Related]
5. Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases.
Ahtiainen M; Elomaa H; Väyrynen JP; Wirta EV; Kuopio T; Helminen O; Seppälä TT; Kellokumpu I; Mecklin JP
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810354
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates for immune checkpoint therapy: significance for CNS malignancies.
Ratnam NM; Frederico SC; Gonzalez JA; Gilbert MR
Neurooncol Adv; 2021; 3(1):vdaa161. PubMed ID: 33506203
[TBL] [Abstract][Full Text] [Related]
7. A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessment.
Lea D; Watson M; Skaland I; Hagland HR; Lillesand M; Gudlaugsson E; Søreide K
Cancer Immunol Immunother; 2021 Jul; 70(7):2049-2057. PubMed ID: 33439293
[TBL] [Abstract][Full Text] [Related]
8. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.
Hu-Lieskovan S; Bhaumik S; Dhodapkar K; Grivel JJB; Gupta S; Hanks BA; Janetzki S; Kleen TO; Koguchi Y; Lund AW; Maccalli C; Mahnke YD; Novosiadly RD; Selvan SR; Sims T; Zhao Y; Maecker HT
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33268350
[TBL] [Abstract][Full Text] [Related]
9. High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer.
Hülsen S; Lippolis E; Ferrazzi F; Otto W; Distel L; Fietkau R; Denzinger S; Breyer J; Burger M; Bertz S; Eckstein M; Ebner A; Hartmann A; Geppert CI
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182484
[TBL] [Abstract][Full Text] [Related]
10. Immune contexture analysis in immuno-oncology: applications and challenges of multiplex fluorescent immunohistochemistry.
Shakya R; Nguyen TH; Waterhouse N; Khanna R
Clin Transl Immunology; 2020; 9(10):e1183. PubMed ID: 33072322
[TBL] [Abstract][Full Text] [Related]
11. Automatic discovery of image-based signatures for ipilimumab response prediction in malignant melanoma.
Harder N; Schönmeyer R; Nekolla K; Meier A; Brieu N; Vanegas C; Madonna G; Capone M; Botti G; Ascierto PA; Schmidt G
Sci Rep; 2019 May; 9(1):7449. PubMed ID: 31092853
[TBL] [Abstract][Full Text] [Related]
12. Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers.
Hänninen UA; Wirta EV; Katainen R; Tanskanen T; Hamberg J; Taipale M; Böhm J; Renkonen-Sinisalo L; Lepistö A; Forsström LM; Pitkänen E; Palin K; Seppälä TT; Mäkinen N; Mecklin JP; Aaltonen LA
Br J Cancer; 2019 Apr; 120(9):922-930. PubMed ID: 30894686
[TBL] [Abstract][Full Text] [Related]
13. Cancer Immunotherapy and Personalized Medicine: Emerging Technologies and Biomarker-Based Approaches.
Maciejko L; Smalley M; Goldman A
J Mol Biomark Diagn; 2017 Sep; 8(5):. PubMed ID: 29285416
[TBL] [Abstract][Full Text] [Related]
14. Beyond PD-L1 testing-emerging biomarkers for immunotherapy in non-small cell lung cancer.
Voong KR; Feliciano J; Becker D; Levy B
Ann Transl Med; 2017 Sep; 5(18):376. PubMed ID: 29057236
[TBL] [Abstract][Full Text] [Related]
15. The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review.
Butterfield LH
Semin Cancer Biol; 2018 Oct; 52(Pt 2):12-15. PubMed ID: 28943324
[TBL] [Abstract][Full Text] [Related]
16. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Hendry S; Salgado R; Gevaert T; Russell PA; John T; Thapa B; Christie M; van de Vijver K; Estrada MV; Gonzalez-Ericsson PI; Sanders M; Solomon B; Solinas C; Van den Eynden GGGM; Allory Y; Preusser M; Hainfellner J; Pruneri G; Vingiani A; Demaria S; Symmans F; Nuciforo P; Comerma L; Thompson EA; Lakhani S; Kim SR; Schnitt S; Colpaert C; Sotiriou C; Scherer SJ; Ignatiadis M; Badve S; Pierce RH; Viale G; Sirtaine N; Penault-Llorca F; Sugie T; Fineberg S; Paik S; Srinivasan A; Richardson A; Wang Y; Chmielik E; Brock J; Johnson DB; Balko J; Wienert S; Bossuyt V; Michiels S; Ternes N; Burchardi N; Luen SJ; Savas P; Klauschen F; Watson PH; Nelson BH; Criscitiello C; O'Toole S; Larsimont D; de Wind R; Curigliano G; André F; Lacroix-Triki M; van de Vijver M; Rojo F; Floris G; Bedri S; Sparano J; Rimm D; Nielsen T; Kos Z; Hewitt S; Singh B; Farshid G; Loibl S; Allison KH; Tung N; Adams S; Willard-Gallo K; Horlings HM; Gandhi L; Moreira A; Hirsch F; Dieci MV; Urbanowicz M; Brcic I; Korski K; Gaire F; Koeppen H; Lo A; Giltnane J; Rebelatto MC; Steele KE; Zha J; Emancipator K; Juco JW; Denkert C; Reis-Filho J; Loi S; Fox SB
Adv Anat Pathol; 2017 Nov; 24(6):311-335. PubMed ID: 28777143
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy biomarkers 2016: overcoming the barriers.
Gulley JL; Berzofsky JA; Butler MO; Cesano A; Fox BA; Gnjatic S; Janetzki S; Kalavar S; Karanikas V; Khleif SN; Kirsch I; Lee PP; Maccalli C; Maecker H; Schlom J; Seliger B; Siebert J; Stroncek DF; Thurin M; Yuan J; Butterfield LH
J Immunother Cancer; 2017 Mar; 5(1):29. PubMed ID: 28653584
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers immune monitoring technology primer: Immunoscore® Colon.
Hermitte F
J Immunother Cancer; 2016; 4():57. PubMed ID: 27660711
[No Abstract] [Full Text] [Related]
19. [Immunoscore and Its Predictive Value for Colorectal Cancer].
Závadová E; Špaček J; Vočka M; Konopásek B; Fučíková T; Netíková I; Dundr P; Skálová H; Petruželka L
Klin Onkol; 2015; 28 Suppl 4():4S82-5. PubMed ID: 26647895
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
